Galen Growth, the leading HealthTech intelligence, analytics and advisory firm serving Fortune 500 companies and global investors, which has been tracking the Asia Pac digital health ecosystem for the past 5 years, announced that 2019 Asia Pac HealthTech breaks more records, reflecting the significant opportunity and the speed of innovation across the region.

Some of the noteworthy headlines for this year include:

• Asia Pac HealthTech ecosystem momentum continues despite geopolitical and domestic headwinds to close at US$5B invested, across 340 deals, well ahead of our forecast last October
• Early-stage and Series A deal activity shrinks yet further, whereas total Series B deal value share continues to grow, raising questions on the forward quality of deals by Growth stage investors and the likely impact on Seed stage ventures
• China slows with dollars to VC-backed ventures shrinking. Are investors being spooked by geo-political and domestic economic headwinds?
• India’s momentum, after a significant dip in value and volume in Q1, accelerated to make 2019 a record-breaking year
• SE Asia investment also broke all previous records and doubled in 2019, reflecting its growing ecosystem maturity
• New in our annual report, we spotlight both the Japan and S Korea ecosystems as these have grown substantially

Overall, both industry and investor sentiment for HealthTech in Asia Pac continues to be strong. The majority of corporate leaders continue to be concerned by their strategy whereas rising numbers of investors see deal flow access as challenging.